AJGP
HOME HELP FEEDBACK SUBSCRIPTIONS ALL ISSUES SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a Colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Taylor, M. P.
Right arrow Articles by Kupfer, D. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Taylor, M. P.
Right arrow Articles by Kupfer, D. J.
Am J Geriatr Psychiatry 7:41-47, February 1999
© 1999 American Association for Geriatric Psychiatry


Regular Article

EEG Sleep Measures in Later-Life Bereavement Depression

A Randomized, Double-Blind, Placebo-Controlled Evaluation of Nortriptyline

Matthew P. Taylor, Charles F. Reynolds, III, M.D., Ellen Frank, Ph.D., Mary Amanda Dew, Ph.D., Sati Mazumdar, Ph.D., Patricia R. Houck, M.S.H., and David J. Kupfer, M.D.

Received August 20, 1997; revised December 9, 1997; accepted February 9, 1998. From the Mental Health Clinic Research Centers for the Study of Late-Life Mood Disorders and Affective Disorders, Western Psychiatric Institute and Clinic, University of Pittsburgh, 3811 O'Hara Street, Pittsburgh, PA 15213. Address correspondence to Dr. Reynolds.

The authors examined 1) effects of nortriptyline (NT) on electroencephalographic (EEG) sleep measures in elderly patients with bereavement-related depression in remission under randomized, double-blind, placebo-controlled conditions, and 2) the effects of clinical remission on sleep after discontinuation of medication. Subjects were classified as responders to placebo (n=9) or NT (n=18) and had EEG sleep studies at three time-points: before treatment (T1), remitted on medication or placebo (T2), and remitted off medication or placebo (T3). As compared with placebo, NT was differentially associated with decreases in REM sleep time and percent and increases in REM sleep density (T2). No changes in EEG sleep measures occurred in placebo responders. REM sleep measures in NT responders reverted to T1 levels after T3, with persistence of robust clinical remission and normal subjective sleep quality. These data suggest that NT alters REM sleep, but that EEG sleep characteristics in bereavement-related depression persist into remission.

Key Words: EEG Sleep • Bereavement Depression • Nortriptyline




This article has been cited by other articles:


Home page
Acad. PsychiatryHome page
L. E. Krahn, M. R. Hansen, and J. A. Tinsley
Psychiatric Residents' Exposure to the Field of Sleep Medicine: A Survey of Program Directors
Acad Psychiatry, December 1, 2002; 26(4): 253 - 256.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ALL ISSUES SEARCH TABLE OF CONTENTS
Copyright © 1999 American Association for Geriatric Psychiatry